Back to search

University of South Florida

Group B <em>Streptococcus</em> Intestinal Barrier Disruption and the Protective Role of Butyrate

Abstract

dc:description

Group B Streptococcus (Streptococcus agalactiae; GBS) is a leading cause of neonatal sepsis worldwide. Intrapartum antibiotics in GBS-colonized mothers significantly reduced the incidence of early-onset sepsis occurring in the first week of life; however, there are currently no prophylactic interventions for late-onset sepsis, occurring within the first 3 months of life. GBS is a pathobiont that primarily colonizes the gastrointestinal tract and can cross the intestinal barrier via both the paracellular and transcellular routes, causing invasive disease. Neonatal susceptibility to GBS intestinal translocation is mediated by inadequate epithelial barrier function and microbiome immaturity; however, the mechanisms by which GBS exploits the immature host remain unclear. β-hemolysin/cytolysin (βH/C) is a highly conserved, pore-forming, rhamnolipid toxin produced by GBS that contributes to the development of sepsis, pneumonia, meningitis, chorioamnionitis, and uropathogenesis. Rhamnolipid toxins can enhance intestinal paracellular translocation via disruption of epithelial tight junction proteins. GBS βH/C disrupts barriers in other tissues but, its role in disrupting the intestinal barrier remains unexplored. That is, βH/C is a key virulence factor that may contribute to intestinal barrier disruption and GBS translocation. The microbiome is tightly linked to intestinal barrier function; indeed, the absence of keystone microbes, i.e., fiber degraders, contributes to a virulent uprising in pathobionts and bacterial translocation. These microbes metabolize dietary fiber into butyrate, a short-chain fatty acid that promotes and restores intestinal barrier function via tight junction protein modulation and direct antimicrobial activity. Maternal diet primes the neonatal intestinal environment and, more specifically, maternal butyrate treatment increases keystone microbes, butyrate production, and fortifies intestinal barrier integrity in offspring. Despite the importance of the intestinal barrier function in protecting the host from enteric pathogens, its relevance to GBS late-onset sepsis is largely unexplored. Our objective was to determine βH/C-mediated effects on intestinal barrier function and the influence of maternal butyrate treatment on GBS disease in offspring. Our overriding hypothesis was that GBS invasive disease is driven by βH/C-mediated intestinal barrier disruption and that maternal butyrate treatment will bolster offspring intestinal barrier function and prevent GBS translocation.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Medical Sciences
Grantor
University of South Florida
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dominguez, Kristen
Contributors dc:contributor
  • Tara M. Randis, MS, MD
  • Sophie E. Darch, Ph.D.
  • Burt Anderson, Ph.D.
  • Larry Dishaw, Ph.D.
  • Andreas Seyfang, Ph.D.

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10499

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Dominguez, Kristen. Group B <em>Streptococcus</em> Intestinal Barrier Disruption and the Protective Role of Butyrate. Dissertation thesis, University of South Florida, 2024. https://digitalcommons.usf.edu/etd/10499